CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2021$1,560,000
+42.9%
433,4000.0%0.00%0.0%
Q4 2020$1,092,000
-2.1%
433,400
-2.1%
0.00%0.0%
Q3 2020$1,115,000
-21.2%
442,500
+2.6%
0.00%0.0%
Q2 2020$1,415,000
+58.8%
431,400
+18.6%
0.00%0.0%
Q1 2020$891,000
-48.1%
363,7940.0%0.00%
-50.0%
Q4 2019$1,717,000
+34.9%
363,794
+22.3%
0.00%
+100.0%
Q3 2019$1,273,000
-1.0%
297,394
+34.9%
0.00%
-50.0%
Q2 2019$1,286,000
+76.9%
220,498
+16.8%
0.00%
+100.0%
Q1 2019$727,000
+105.9%
188,7660.0%0.00%
Q4 2018$353,000
-41.6%
188,7660.0%0.00%
-100.0%
Q3 2018$604,000
-9.7%
188,766
-14.8%
0.00%0.0%
Q2 2018$669,000
-20.0%
221,552
+3.9%
0.00%0.0%
Q1 2018$836,000
-5.3%
213,1660.0%0.00%0.0%
Q4 2017$883,000
-32.5%
213,1660.0%0.00%
-50.0%
Q3 2017$1,309,000
-1.3%
213,1660.0%0.00%0.0%
Q2 2017$1,326,000
-47.8%
213,166
-51.1%
0.00%
-50.0%
Q1 2017$2,541,000
+113.5%
435,532
+95.9%
0.00%
+100.0%
Q4 2016$1,190,000
-5.0%
222,3660.0%0.00%0.0%
Q3 2016$1,252,000
-4.1%
222,366
-6.4%
0.00%0.0%
Q2 2016$1,305,000
-28.2%
237,666
-3.0%
0.00%
-33.3%
Q1 2016$1,818,000
-28.8%
245,066
-20.3%
0.00%
-25.0%
Q4 2015$2,554,000
+515.4%
307,366
+567.2%
0.00%
+300.0%
Q3 2015$415,000
+3672.7%
46,066
+1488.5%
0.00%
Q3 2013$11,000
+83.3%
2,9000.0%0.00%
Q2 2013$6,0002,9000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders